You can read the abstract of this article at In a Phase 3 trial involving 1879 individuals with type 2 diabetes (T2D) on metformin, Tirzepatide (TZP) at doses of 5 and 15 mg demonstrated substantial improvements in HbA1c and weight reduction compared to 1 mg of semaglutide (SEMA)
Many practitioners separate them by 30 to 60 minutes simply to attribute any injection-site reactions to one agent
Bayley EM, Zhou N, Mitchell KG, Antonoff MB, Mehran RJ, Rice DC, Sepesi B, Swisher SG , Vaporciyan AA, Walsh GL, Cinciripini PM, Karam-Hage M, Roth JA, Hofstetter WL
Targeting AngII/AT1R signaling pathway by perindopril inhibits ongoing liver fibrosis in rat
Moreover, Gao et al